Effect of aging on tumor microenvironment
ESH eLearning, Hartmut Geiger, 165659
Dynamic interactions between normal and malignant haematopoietic cells and their niches
ESH eLearning, Cristina Lo Celso, 165660
A systems biological perspective on stem cell / niche interactions
ESH eLearning, Ingo Roeder, 165661
ESH eLearning, Anna v, 165443
ESH eLearning, Raphaël Itzykson, 165444
Treatment of lower risk MDS (non del 5q)
ESH eLearning, Eva Hellstrom-Lindberg, 165445
Allogeneic SCT
ESH eLearning, Nicolaus Kröger, 165446
Overview of new drugs, clinical trials, and international cooperative efforts in clinical research
ESH eLearning, Pierre Fenaux, 165447
Molecularly defined MDS and MDS/MPN
ESH eLearning, Pierre Fenaux, 165448
Do we need a different niche for fast haematopoietic reconstitution in cord blood transplantation?
ESH eLearning, G. Koegler, 165498
Emergence of fetal immune-restricted lympho-myeloid progenitors prior to definitive haematopoietic stem cells
ESH eLearning, S.E. Jacobsen, 165499
Cord blood stem cells acquire the signature of induced pluripotent stem cells (iPS) when transplanted
ESH eLearning, F. Frassoni, 165500
Nicord expands haematopoietic stem cells and shortens time to engraftment in patients undergoing cord blood transplantation for haematological malignancies and sickle cell disease
ESH eLearning, J. Kurtzberg, 165501
Rescue of the mucocutaneous manifestations in a mouse model of recessive dystrophic epidermolysis bullosa (RDEB) by human cord blood (CB) derived unrestricted somatic stem cells (USSCS)
ESH eLearning, M. Cairo, 165502
History and future of cord blood transplantation
ESH eLearning, E. Gluckman, 165503
Single versus double cord blood transplant in children
ESH eLearning, J. Wagner, 165504
Introduction of the Cord Blood Bank Technology Survey (WMDA-NetCord)
ESH eLearning, E. Baudoux, 165505
Cost efficiency of cord blood banks
ESH eLearning, S. Querol, 165506
Contribution of Eurocord registry to the improvement of cord blood banking
ESH eLearning, I. Ionescu, 165507
State of the art
ESH eLearning, E. Petersdorf, 165508
Analysis of classical HLA haplotypes can predict outcomes of haematopoietic stem cell transplantation
ESH eLearning, R. Tamouza, 165509
IRES: an immune reconstitution study of umbilical cord blood transplant recipients
ESH eLearning, J. Girdlestone, 165510
Importance of CD4+ lymphocyte reconstitution following cord blood transplantation
ESH eLearning, P. Veys, 165511
Towards individualized conditioning regimens to improve the outcomes of cord blood transplantation
ESH eLearning, J. Boelens, 165512
How to improve cord blood transplant results in adults
ESH eLearning, J. Sanz, 165513
Prevention of GVHD by umbilical cord blood derived T- regulatory cells
ESH eLearning, J. Wagner, 165514
Prospective study on allogeneic transplant in acute myeloid leukaemia according to the policy of the Rome Transplant network for donor selection: HLA identical sibling vs matched unrelated vs haploidentical related donor
ESH eLearning, W. Arcese, 165515
Assessment of adhesion and homing molecules alteration in ex vivo expansion of umbilical cord blood CD34+ haematopoietic stem cells
ESH eLearning, M. N. Zarif, 165516
Comparison of HLA-G expression in mesenchymal stromal cells derived from bone marrow, placenta, umbilical cord and amniotic membrane
ESH eLearning, M. N. Zarif, 165517
Inventory depuration
ESH eLearning, L. Ponce-Verdugo, 165518
Clinical utility of family-directed cord blood storage
ESH eLearning, M. Abecasis, 165519
Clinical utility of family-directed cord blood storage
ESH eLearning, M. Abecasis, 165520
Comparison of the results of haemoglobin pattern screened in different public health services: umbilical cord blood bank of the Hospital de Clínicas de Porto Alegre (BSCUP-HCPA) and newborn screening reference service of Rio Grande Do Sul (SRTN-RS), Brazil
ESH eLearning, L.M. Röhsig, 165521
Substantially reduced red cell contamination with comparative nucleated cell recovery using sample specific red cell depletion and plasma reduction technique (a retrospective analysis of 9637 umbilical cord blood units at LifeCell International, India)
ESH eLearning, P. Dhot, 165522
Umbilical cord blood collection: first year operations at the Canadian Blood Services, National Public Cord Blood Bank
ESH eLearning, H. Elmoazzen, 165523
Treatment of sickle cell disease in emerging countries
ESH eLearning, M. de Montalembert, 165524
Indication of bone marrow transplantation in sickle cell disease
ESH eLearning, F. Bernaudin, 165525
International survey of haematopoietic stem cell transplant from an HLA identical sibling for sickle cell disease
ESH eLearning, B. Cappelli, 165526
Establishing a cost-effective national cord blood registry in a resource restricted environment
ESH eLearning, S. Narayan, 165527
A potential treatment for beta-thalassemia and sickle cell disease via high-efficiency targeted genome editing of hematopoietic stem cells
ESH eLearning, M. Walters, 165528
Gene therapy for hereditary disorders
ESH eLearning, J.A Ribeil, 165529
Indications and results of the use of stem cells for regenerative medicine
ESH eLearning, G. Koegler, 165530
The red cell: from genesis to death
ESH eLearning, Oliver Hermine, 95254
Closing debate
ESH eLearning, Dr. Martin Colard and Dr. Corentin Orvain, 95402
Closing debate: The future of red cell pathologies among (European) medical professionals: are there new young haematologists in this field?
ESH eLearning, Dimitris Loukopoulos, 95017
Iron overload in thalassaemia and sickle cell disease
ESH eLearning, Maria Domenica Cappellini, 95015
Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications
ESH eLearning, Oliver Hermine, 95253
Gene therapy in thalassaemia and sickle cell disease
ESH eLearning, Yves Beuzard, 95014
Bone marrow transplantation in thalassaemia and sickle cell disease, including haploidentical BMT
ESH eLearning, Alina Ferster, 95013
Guidelines for the biological diagnosis of haemoglobinopathies
ESH eLearning, C.L. Harteveld, 95012
Unstable haemoglobins: Physiopathology, clinical and biological diagnosis
ESH eLearning, Patricia Aguilar-Martinez, 95011
Laboratory diagnosis of abnormal haemoglobins, an update - From phenotype to genotype
ESH eLearning, Frederic Cotton, 95016
Sickle cell disease in adults and elderly patients: Emerging complications and management
ESH eLearning, Lucia De Franceschi, 95010
Sickle cell disease (SCD) in children and adolescents
ESH eLearning, Mariane de Montalembert, 95009
Alpha-thalassaemia: new fast test for the molecular diagnosis
ESH eLearning, C.L. Harteveld, 95008
Beta-thalassaemia: from CBC to DNA: methodologies and laboratory diagnosis
ESH eLearning, Patricia Aguilar-Martinez, 95007
Beta-thalassaemia: clinical findings, molecular defects genotype / phenotype relationship
ESH eLearning, Maria Domenica Cappellini, 95005
Recommendations for the recognition of centres of expertise on haemoglobinopathies in Europe
ESH eLearning, Joan-LLuis Vives-Corrons, 95004
Prevention programmes for thalassaemia and sickle cell disease: past and present
ESH eLearning, Michael Angastiniotis, 95003
Prevention of severe forms of haemoglobinopathies: Newmethodologies and procedures
ESH eLearning, Marina Kleanthous, 95001
Neonatal screening for sickle cell disease in European countries: where are we in 2015?
ESH eLearning, BEATRICE GULBIS, 95000
Migrations and haemoglobin disorders: current status in European countries
ESH eLearning, Maria del Mar MANU (Mañú), 94999
Introduction to the course
ESH eLearning, Patricia Aguilar-Martinez, 95252
Communication Skills
ESH eLearning, Session Speakers, 98455
Epidemiology of MDS and environmental factors
ESH eLearning, D. Bowen, 165409
Germline mutations predisposing to MDS
ESH eLearning, Brigitte Schlegelberger, 165410
Myelodysplastic stem cells
ESH eLearning, P. Woll, 165413
ESH eLearning, G. Göhring, 165415
Flow Cytometry in the Diagnostic Work-up of Myelodysplastic Syndromes
ESH eLearning, T. Westers, 165417
Molecular Biology
ESH eLearning, T. Haferlach, 165419
Prognosis and risk assessment
ESH eLearning, L. Malcovati, 165421
Predictive factors for response to treatment
ESH eLearning, R. Itzykson, 165423
Pathophysiology and treatment of anaemia in MDS
ESH eLearning, E. Hellström-Lindberg, 165424
Management of MDS with del(5q)
ESH eLearning, M. Jädersten, 165425
High risk MDS
ESH eLearning, L. Ades, 165426
Allogeneic HSCT
ESH eLearning, T. De Witte, 165427
Experimental transplantation approaches
ESH eLearning, N. Kröger, 165428
Apoptosis and erythroid differentiation
ESH eLearning, G. Courtois, 165650
Autophagy and erythroblast maturation
ESH eLearning, V. Betin, 165651
Epidemiology, pathophysiology and treatment of high altitude polycythemia (Monges’s disease)
ESH eLearning, J.P. Richalet, 165652
Large-scale erythroid differentiation using iPS cells
ESH eLearning, L. Douay, 165653
Not so benign haematology: anaemia of the elderly
ESH eLearning, C.N. Roy, 165654
Novel erythropoiesis-stimulating agents: a new era in anaemia management
ESH eLearning, I. Macdougall, 165655
Malaria: pathology and cytoadherence
ESH eLearning, A. Merckx, 165656
Modifier genes in sickle cell disease
ESH eLearning, J. Elion, 165657
Current diagnostics in- and classification of NHL, including demonstration of diagnostic pitfalls
ESH eLearning, A. Rosenwald, 165472
Staging and response evaluation, including the role of PET/CT scanning, including demonstration of pitfalls in imaging
ESH eLearning, M. Hutchings, 165473
Treatment options, including clinical cases, controversies
ESH eLearning, A. Hagenbeek, 165474
Treatment options, including clinical cases, controversies
ESH eLearning, M. Dreyling, 165475
Current diagnostics and staging of MM, including demonstration of diagnostic pitfalls
ESH eLearning, H. Goldschmidt, 165476
Stratification and response evaluation, including demonstration of pitfalls
ESH eLearning, H. Avet-Loiseau, 165477
Treatment options, including clinical cases, controversies
ESH eLearning, M.V. Mateos, 165478
Treatment options, including clinical cases, controversies
ESH eLearning, G. Merlini, 165479
State of the art including methods for graft facilitation
ESH eLearning, H.E. Broxmeyer, 165531
Cord blood subpopulations and reprogrammed cells
ESH eLearning, G. Koegler, 165532
Role of registries to analyze outcomes data – Eurocord – Netcord
ESH eLearning, V. Rocha, 165547
Sickle cell disease global perspective
ESH eLearning, E. Gluckman, 165548
Networks, research tools and cooperation: the example of network research on sickle cell disease in Central Africa
ESH eLearning, L. Tshilolo, 165563

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Save Settings